A detailed history of Tudor Financial Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tudor Financial Inc. holds 4,834 shares of BMY stock, worth $284,142. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,834
Holding current value
$284,142
% of portfolio
0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$39.66 - $51.75 $191,716 - $250,159
4,834 New
4,834 $250 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tudor Financial Inc. Portfolio

Follow Tudor Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tudor Financial Inc. with notifications on news.